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ABSTRACT
Objectives: The UK-developed patient measure of
safety (PMOS) is a validated tool which captures
patient perceptions of safety in hospitals. We aimed (1)
to investigate the extent to which the PMOS is
appropriate for use with stroke, acute myocardial
infarction (AMI) and hip fracture patients in Australian
hospitals and (2) to pilot the PMOS for use in a large-
scale, national study ‘Deepening our Understanding of
Quality in Australia’ (DUQuA).
Participants: Stroke, AMI and hip fracture patients
(n=34) receiving care in 3 wards in 1 large hospital.
Methods: 2 phases were conducted. First, a ‘think
aloud’ study was used to determine the validity of
PMOS with this population in an international setting,
and to make amendments based on patient feedback.
The second phase tested the revised measure to
establish the internal consistency reliability of the
revised subscales, and piloted the recruitment and
administration processes to ensure feasibility of the
PMOS for use in DUQuA.
Results: Of the 43 questions in the PMOS, 13 (30%)
were amended based on issues patients highlighted for
improvement in phase 1. In phase 2, a total of 34
patients were approached and 29 included, with a
mean age of 71.3 years (SD=16.39). Internal
consistency reliability was established using interitem
correlation and Cronbach’s α for all but 1 subscale.
The most and least favourably rated aspects of safety
differed between the 3 wards. A study log was
categorised into 10 key feasibility factors, including
liaising with wards to understand operational
procedures and identify patterns of patient discharge.
Conclusions: Capturing patient perceptions of care is
crucial in improving patient safety. The revised PMOS
is appropriate for use with vulnerable older adult
groups. The findings from this study have informed
key decisions made for the deployment of this measure
as part of the DUQuA study.
BACKGROUND
Over the past two decades, the patient safety
movement has urged hospitals to improve
the safety of their practices.1–4 Although
patients are frequently surveyed on the satis-
faction of their experiences in hospital, these
surveys do not capture information that can
be used to improve safety of care.5 Patients’
own perceptions of the care provided to
them is an overlooked yet well-placed
resource for understanding the factors
responsible for safety of care.6 Patients have
demonstrated a willingness and capability to
provide valuable feedback on both the safety
of care delivered to them, and of the care
environment (eg, delays to treatment, faulty
equipment, miscommunication)—factors
that busy healthcare professionals may not
observe or report.5 7 With the right tools,
patients can help hospitals to proactively
identify safety issues, in order to intervene
and prevent incidents from occurring.6
In recognition of this, a group of health-
care quality and safety experts in the UK
developed the patient measure of safety
(PMOS).5 6 The PMOS is the ﬁrst valid and
reliable tool that asks patients to comment
on the factors that inﬂuence patient safety,
Strengths and limitations of this study
▪ This was the first time the patient measure of
safety (PMOS) has been used in Australia.
▪ The sample size was targeted and modest, and
limited to one site. Nonetheless, the participants
were representative of the population that will be
surveyed in the forthcoming national Deepening
our Understanding of Quality in Australia
(DUQuA) study.
▪ Researchers partnered with hospital leaders and
healthcare professionals to implement participant
recruitment and data collection processes that
can be replicated.
▪ This study investigated feasibility of data collec-
tion with vulnerable older adult patients, which is
of importance given the expected growth in older
persons globally.
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according to a validated contributory factors framework
of patient safety.8 It has been designed such that hospi-
tals and wards can use it as a diagnostic guide for the
design of patient safety improvement interventions by
front-line staff.
While a measure to gain information about patient
perceptions of safety can be useful, identifying whether
patient perceptions of safety are associated with (1) how
hospitals set themselves up for quality and safety, (2) the
way care is delivered and (3) health outcomes for
patients, is yet to be established. Understanding the
extent of these relationships can assist policymakers and
hospital leaders in making decisions about the target
areas to invest resources to improve the quality and
safety of healthcare.9 A large national study, ‘Deepening
our Understanding of Quality in Australia’ (DUQuA;9 a
modiﬁed replication of a European study of 188 hospi-
tals (DUQuE)10), aims to explore the relationships
between organisation and department-level quality man-
agement systems and patient factors in 60 large public
hospitals across Australia.9 One of the factors that will be
measured in DUQuA is patient-reported perceptions of
safety, and for this the PMOS will be used.i
The patient conditions selected for the DUQuA study
are stroke, acute myocardial infarction (AMI) and hip
fracture. Thirty patients within each of these condition
groups will be surveyed in each hospital (estimated total
of 5400 patient participants) using the PMOS. However,
to date, the PMOS has neither been tested in the
Australian setting, nor with a principally vulnerable
older adult population (the mean (SD) age of the ori-
ginal validation sample was 54 (18.13) years). Since
stroke, AMI and hip fracture predominantly affect older
adults in Australia,12–14 they are a particularly vulnerable
sample due to the prevalence of condition-related com-
plications or age-related comorbidities.15–19 As such, it is
highly probable that these patients may experience pain
or fatigue, and may suffer cognitive, hearing or visual
impairments; factors that must be considered when plan-
ning recruitment, consent and data collection, and
which can severely impact the quality and reliability of
data.20–22 Therefore, it is important to identify and
improve the suitability of the PMOS for use with this
population prior to the full deployment of the measure.
Finding strategies to overcome the challenges of under-
taking research with hospitalised older adults23 is of sig-
niﬁcance due to an ageing population, and expected
global growth of older persons—a factor associated with
an increase in health expenditure.24
It is also crucial to ensure that the processes for con-
ducting research with in-hospital AMI, stroke or hip frac-
ture patients are appropriate, risk-free, consistent and
effective. The large-scale nature of the national DUQuA
study necessitates piloting the PMOS to explore ways to
establish efﬁcient, rigorous, pragmatic and ethical pro-
cesses that can be replicated by the data collectors who
will administer the measure in 60 Australian hospitals.9
OBJECTIVES
The objective of this study was to investigate whether the
PMOS is appropriate to be used for stroke, AMI and hip
fracture patients in Australian hospitals in order to
ensure the feasibility of using this measure in the
DUQuA study. The study had two phases. Phase 1, ‘think
aloud’, aimed to test the face validity of the PMOS with
the intended population for DUQuA (ie, Australian hos-
pitalised older and vulnerable adults), and identify if
amending the PMOS would improve understanding by,
and relevance for, this population. Phase 2 aimed to test
the revised measure to establish the internal consistency
reliability of the revised subscales, and to pilot the
PMOS to identify key areas within the recruitment and
administration processes that could inform and enhance
the feasibility of the DUQuA study.
METHODS
Hospital engagement
The research team contacted the quality manager (QM)
at a large metropolitan public hospital that has also
enrolled in the DUQuA study. The research team
advised the QM of two beneﬁts for participating as the
PMOS pilot site: provision of a report on patients’ per-
ceptions of safety across the three wards, and that the
experience would familiarise the hospital with data col-
lection processes prior to the DUQuA study. The QM
agreed that the hospital would participate as the pilot
site for this study.
Participants
Sample type and size
Given that (1) the ﬁrst ﬁve participants should usually
reveal around 85% of the problems available for discov-
ery in that iteration of an instrument25 26 and (2) an
extensive amount of ‘think aloud’ research was under-
taken on the originally developed PMOS, ﬁve patients
with stroke were approached to participate in the ‘think
aloud’ (phase 1). Stroke was selected as the most vulner-
able cohort of the three conditions, due to the
iThe original DUQuE study found that patient experience showed no
relationship with hospital quality management strategies.11 However, in
the DUQuE study, the Nordic Patient Experiences Questionnaire
(NORPEQ) was used, for which we identiﬁed some limitations that
may have inﬂuenced the strength of the relationship. More speciﬁcally,
in the NORPEQ development and validation study, the questionnaire
was completed by patients independently at home following in-patient
care, and the measure does not have any scales to measure
experiences of safety; whereas in the DUQuE study used in-hospital
patient completion, and the measures of quality management systems
that were compared with the NORPEQ results focused primarily on
‘patient safety’ (as opposed to general experience).
The original PMOS was developed and validated with an in-hospital
patient sample, and measures patient experiences of safety on the ward
which provided the majority of their care. The PMOS is also designed
based on contributory factors to patient safety framework. For these
reasons, and the issues outlined with the measures used in the original
DUQuE study, the PMOS was identiﬁed as an appropriate tool for our
national DUQuA study.
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sensorimotor, communication and cognitive complica-
tions (eg, speech or hand impairments) faced by hospi-
talised patients with stroke.27 Recruitment continued
until there was evidence of data saturation, consistent
with other ‘think aloud’ studies.28 29
For phase 2, guidance was taken from the literature
on appropriate sample sizes for pilot studies testing a
new scale (n=30).30 As this was a pilot study, it was
deemed appropriate to collect 10 PMOS questionnaires
per ward, giving a total of 30 participants.
Eligibility
Detailed criteria were required to ensure the exclusion
of patients who lacked the cognitive ability to give
informed consent or who would be overly burdened by
participation. Inclusion and exclusion criteria for both
study phases are presented in table 1.
Measure
The PMOS items were developed based on 33 interviews
with inpatients from six units in one UK teaching hos-
pital about their perceptions of patient safety.5 The face
validity of the measure was established via 12 patients
and 12 healthcare professionals. Following this, 297
patients from 11 hospital wards completed the PMOS
questionnaire. Factor analysis revealed nine key domains
of safety6 indicated in table 2, which align with a vali-
dated framework of contributory factors to patient
safety.8 Items on the PMOS are phrased both positively
and negatively, and scored using a ﬁve-point Likert scale
(strongly disagree to strongly agree). Following reverse
scoring for negative items, higher total scores represent
more favourable responses.
DATA COLLECTION
Identifying and approaching patients
The research lead (NT) was introduced to the nurse
unit managers (NUMs) for each ward by the QM.
The research lead liaised with each NUM to deter-
mine a communication process to identify patients efﬁ-
ciently, causing as little disruption to normal working
practice as possible. Over a 3-month period, a member
of the research team called the wards on 1–2
mornings per week to determine if any eligible
patients were due to be discharged from hospital. In
the orthogeriatric ward, the research lead was pro-
vided with a list of highlighted patient names and bed
numbers. In the stroke and cardiac wards, the NUM
informed the research lead of the patient name and
bed number.
Once identiﬁed, the research lead approached the
patient with a standard introduction (box 1), which was
adjusted (eg, through language simpliﬁcation, emphasis-
ing word pronunciation, reducing the speed of word
ﬂow or repetition) based on individual patient responses
or needs.
Consent and screening
From the initial approach to ﬁnalising questionnaire
administration, the research lead screened the consent-
ing patients using a list of cues developed by Harris and
Dyson22 (box 2). If the patient at any time demonstrated
a lack of understanding of consent as per these cues,
the patient was excluded from the study, regardless of
the provision of consent.
Table 1 Participant inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
▸ Experienced the care of
stroke, cardiac or
orthogeriatric wards as a
stroke, AMI or hip
fracture patient*
▸ Deemed well enough by
a ward nurse or doctor
for the researcher to
approach
▸ Provided with notification,
verbally or in writing, of
discharge
▸ Willing to give written
informed consent
▸ Willing to participate in
the study
▸ No capacity to give
informed consent (eg,
suffering from dementia,
delirium or confusion)
▸ Suffering from physical
or emotional distress
(eg, in pain, having
recently received bad
news)
▸ Unable to communicate
in English (unless a
carer or family member
would act as an
interpreter)
▸ Under the age of 18
▸ Currently enrolled in a
clinical trial
*Refer to the full DUQuA study protocol9 for primary diagnosis
admission codes for each condition.
AMI, acute myocardial infarction; DUQuA, Deepening our
Understanding of Quality in Australia.
Table 2 Patient measure of safety subscales and
example items
Subscale (n items) Example item
Communication and
team work (10)
I always felt staff listened to me
about my concerns
Organisation and care
planning (5)
Staff gave me different
information about my care
Access to resources (4) Staff seemed to struggle to get
help when they needed it
Ward type and layout
(11)
Staff were prompt in answering
my buzzer
Information flow (3) After a shift change staff
appeared to know important
information about my care
Roles and
responsibilities (4)
It wasn’t clear to me who was
in charge of my care
Staff training (2) On at least one occasion a
member of staff was not able to
use the necessary equipment
Equipment design and
functioning (2)
Equipment needed for my care
was always working properly
Delays (2) My treatment/procedure/
operation always happened on
time
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Considerations for using the PMOS with vulnerable older
adult patients
The PMOS could be completed either by the patient, or
with assistance from a researcher.6 The research team
anticipated that in implementing this measure with this
group of participants, it would be likely that they would
request assistance.31 The research lead used evidence-
based techniques for interacting with older adult partici-
pants (eg, sit facing the patient, ensure lips are visible to
the patient, check patients have their hearing aids or
glasses if necessary, speak slowly and clearly, use visuals
aids and large fonts).32 To assist patients with visual,
speech or physical impairments,31 and to protect privacy
of participants who may be concerned about others
overhearing their answers on the ward,33 an enlarged
Likert scale was designed for patients to point to as a
way of indicating answers. The research lead also offered
to read questions aloud, and at a slower pace, for
patients with visual or hearing impairments, or both.
‘Thank you’ cards were provided for all patients who
participated in the study.34
Phase 1—‘think aloud’
The ‘think aloud’ method has previously been used to
assess validity and feasibility of health and social care
measures for use with older adults,28 and was also used
to assess face validity during the development of the ori-
ginal PMOS.5 During the ‘think aloud’ phase, the
research lead sat with patients as they worked through
the PMOS and prompted them to identify and elaborate
on aspects of the questionnaire that were difﬁcult to
understand or presented cultural differences in termin-
ology. Patients were asked to consider and discuss the
following features with the research lead, who made
notes during the conversation: presentation, termin-
ology, content, phrasing and the number of questions.
Phase 2—testing the revised PMOS
Following amendments to the PMOS based on the
‘think aloud’, the revised measure was tested with
patients recruited across the stroke, cardiac and ortho-
geriatric wards. The majority of participants requested
assistance from the research lead in the form of reading
out the questions and writing down answers. The
average length of time to complete was ∼20 min per
patient, ranging from 10 to 30 min.
Pilot test for the DUQuA study
From the outset of the study, the research team kept a
project log of potentially relevant and important occur-
rences—any facet that may affect the feasibility of using
the questionnaire. This included records of communica-
tion with the hospital’s research ofﬁce, conversations
with ward staff, the research lead’s observations of acces-
sing wards, interacting with patients and family
members, and administering the questionnaire. These
occurrences were discussed by the research team during
regular meetings. This was undertaken to inform and
justify key decisions about data collection materials and
processes for future use of the PMOS, in particular for
the DUQuA study.
ANALYSIS
Phase 1—‘think aloud’
The notes made by the research lead were collated and
categorised, generating a list of recommended changes
to the PMOS. Given the extensive development process
in the UK, the research team consulted with the UK
PMOS lead (RL) to discuss the suggested amendments.
A consensus was reached based on ﬁndings from add-
itional studies that had been undertaken or were under-
way in the UK, and revisions were made to the
Australian version of the PMOS.
Box 2 Harris and Dyson’s22 screening cues to assess
current cognitive understanding
▸ Was the patient able to concentrate on the brief introduction?
▸ Did they appear to listen and engage in what the researcher
was saying?
▸ Did they respond appropriately? Did they ask appropriate
questions?
▸ Were there any signs of inconsistency in what they said?
▸ Was there a lot of repetition in what the patient was asking?
▸ Was the conversation appropriate or did the patient talk at
length, constantly going off at tangents?
▸ Were there other agendas and preoccupations that were far
more important to the patient?
▸ If the patient did not appear to understand, how did they deal
with this? Did they deny not understanding? Or make appro-
priate suggestions, for example, using their next of kin to help
them?
▸ Did they appreciate the consequences of consenting or not
consenting?
▸ Did they appear to understand that there was a need for a
decision?
Box 1 Standard introduction for approaching patients
▸ Hi, are you Mrs X? My name is Natalie. I have been told by the
nurse in charge that you are due to be discharged soon—is
that correct? (Patient response…)
▸ I am doing some research with Macquarie University to help
improve this hospital and wondered if you would be willing to
take part in a short patient questionnaire? (Patient response…)
▸ It is just to try and understand a bit more about your experi-
ence of care and safety since you have been on this [AMI/
stroke/hip fracture] ward. It takes about 15 minutes and is con-
fidential. (Patient response…)
▸ I have an information sheet for you to read and if you agree to
take part there is just a consent form to sign. It is up to you
whether you would like to complete the questionnaire yourself,
have me read the questions out to you and you point to the
answers, or a member of your family can help you to complete
it too. (Patient response…)
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Phase 2—revised PMOS reliability test
The reliability of the PMOS subscales were assessed
using interitem correlation for subscales with two items
(r>0.2 acceptable),35–37 and Cronbach’s α for subscales
with more than two items (α>0.7 acceptable).38 For the
total sample and the individual wards, mean (M) and
standard deviation (SD) scores were calculated for each
subscale, as well as a ‘negative index’, representing the
mean number of items that each patient scored nega-
tively (ie, ≤2).6
Pilot test for the DUQuA study
The project log was categorised into a set of key feasibil-
ity factors, with an explanation of how each had affected
the decisions made for the DUQuA study. These key
feasibility factors informed the development of training
materials and resources for DUQuA data collectors.
RESULTS
Phase 1—‘think aloud’
Five patients agreed to participate in the ‘think aloud’
study but on continuous screening during the third con-
sultation, it was clear that this patient was not engaging
with the researcher to answer questions appropriately.
Therefore, the researcher thanked the patient and
informed the NUM that, for this reason, the patient
would be excluded. Consequently, four patient consulta-
tions were included in this phase. All four patients com-
mented on three main areas: item phrasing,
terminology and wording. As no new comments or sug-
gestions were made, no additional patients were
approached for further consultation.
Of the 43 questions in the PMOS, 13 (30%) were
amended based on areas these patients highlighted for
improvement (table 3). Recommended changes
included amending healthcare terms that were less
common in the Australian context, and rephrasing nega-
tively phrased questions to positively framed questions.
Following consultation with the UK team, the decision
to reword all negatively phrased questions was not taken,
as the research team believed in some instances the
intended meaning of the questions would be altered as
a result. The proportion of negatively phrased questions
was therefore reduced from 56% to 28%. The new struc-
ture and reliability levels of the adapted PMOS are
reported following phase 2.
Phase 2—revised PMOS reliability test
Descriptive statistics and revised PMOS reliability
A total of 34 patients were approached following identiﬁ-
cation by the NUMs. One patient declined and two
agreed to participate and signed a consent form, but
later withdrew, citing reasons including feelings of tired-
ness, or the arrival of a physiotherapist for ﬁnal assess-
ment before discharge. Patients agreeing to participate
(n=31) were from the cardiology (n=8), stroke (n=13)
and orthogeriatic wards (n=10). One stroke and one hip
fracture patient agreed to participate but on continuous
screening by the research lead, it appeared they were
confused and consequently these responses were
excluded. Therefore, the number of included patients
was 29 (n=8 cardiology, 12 stroke and 9 hip fracture).
The mean age of participants was 71.3 (SD=16.39)
across all wards (stroke M=69.83, SD=18.89; cardiology
M=62.25, SD=12.81; hip fracture M=82.10, SD=9.56).
Two items with response rates lower than 25% were
removed from analysis: ‘a doctor changed my plan of
care and other staff know about it’, and ‘staff were kept
waiting for my test results’. The indications were that
patients did not know the answers to these questions. All
PMOS subscales demonstrated acceptable reliability,
based on either Cronbach’s α (α>0.7) or interitem cor-
relation (r>0.2), except for the organisation and care
planning subscale, which had a Cronbach’s α of 0.52.
Additional ﬁle 1 compares the Cronbach’s α, interitem
correlations and mean subscale interitem correlations
for the originally tested PMOS and our revised version.
Revised PMOS scores
As illustrated in table 4, the mean PMOS negative index
for the entire sample was 2.59 (SD=2.72), suggesting
that on average people answered 2–3 out of 43 questions
negatively (once all items were reverse scored, a low
score, ie, ≤2/5 indicates a negative answer). Individual
item analysis revealed scores between M (SD)=3.26
Table 3 Modifications to the patient measure of safety
following phase 1
Issues and areas for
improvement PMOS amendments made
Item phrasing
▸ Patients not comfortable
with negatively phrased
items that put staff caring
for them in a bad light
▸ Patients found many
negatively worded
questions confusing
Phrasing reworded
▸ Negatively worded items
were reduced from 56%
to 28% (24–12 items);
did not reword items if
this would change the
intended meaning
Terminology
▸ UK terminology caused
uncertainty, for example,
patients unsure what
‘porters’ were
Terminology changed
▸ UK terms were
substituted with
Australian, for example,
changed ‘porters’ to
‘wardsmen’
Wording
▸ Patients suggested
improvements to
language
Wording modified
▸ Changes were made to
item wording, for
example, ‘staff gave me
different information
about my care’ was
changed to ‘staff gave
me conflicting
information about my
care’
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(0.99; ‘staff were kept waiting for my test results’) and M
(SD)=4.69 (0.47; ‘the drugs I have been prescribed were
always available’)—this item also had the lowest SD, indi-
cating limited use of the rating scale. The extent to
which items were answered with ‘not applicable’ (NA)
ranged from 0 (19 items) to 10 (1 item), with ‘a doctor
changed my plan of care and other staff knew about it’,
and ‘the following aspects of the ward made it difﬁcult
for staff to do their jobs: position of nurses’ station
receiving n=8 NAs and ‘staff were kept waiting for my
test results’ receiving 10.
Among the nine key domains measured in the
PMOS, patients rated staff training most favourably
(M=4.44, SD=0.63) and the delays subscale least
favourably (M=3.89, SD=1.11). It was noted that the
delays subscale only contained two questions, and thus
had a larger SD.
Ward-level results
Patients with stroke had the most favourable answers to
the communication and team work subscale (eg,
patients felt staff listened to their concerns). The roles
and responsibilities subscale received the least favour-
able scores (eg, patients were uncertain about who was
in charge of their care, or of the different roles of those
caring for them).
Patients with AMI rated staff training most favourably
(eg, patients felt staff could use equipment properly and
carry out tasks they should be able to do). The roles and
responsibilities subscale received the least favourable
scores (eg, patients were uncertain about who was in
charge of their care, or of the different roles of those
caring for them).
Hip fracture patients answered more negatively on
average than patients with stroke and AMI. The informa-
tion ﬂow subscale (eg, staff handed information over
between shifts effectively) was the most favourable to hip
fracture patients, and delays (eg, to treatment, or having
too few staff to get things done on time) received the
lowest mean score.
Pilot test for the DUQuA study
A list of 10 key feasibility factors is presented in table 5.
For each factor, the details of ﬁndings from the pilot
study are provided, alongside an explanation of how
each factor has inﬂuenced the decisions made for the
DUQuA study. In addition, the research lead provided
hospital leaders with a report of the results and subse-
quently met to discuss the results in order to gain feed-
back about the report (ie, if the tone was appropriate
and the information valuable), and to discuss how best
to provide the hospital with recommendations for
improvement.
DISCUSSION
Patients have the capacity to signal potential safety inci-
dents early,39 40 and the PMOS has the capacity to reli-
ably and efﬁciently tap into this resource.6 41 Testing the
extent to which the PMOS can capture this information
from vulnerable older adult patients in a reliable and
risk-free way was a key aim of this study. Following a
‘think aloud’, the revised PMOS was tested with patients
with stroke, AMI and hip fracture in one Australian hos-
pital to establish internal consistency reliability of the
revised subscales. While the ‘organisation and care plan-
ning’ produced a Cronbach’s α of 0.52, the comparisons
for the Cronbach’s α, interitem correlations and mean
subscale interitem correlations for the originally tested
PMOS and our revised version demonstrate similar ﬁnd-
ings (additional ﬁle 1), despite our smaller sample size
in our pilot study. Throughout the study, the research
team identiﬁed key factors relating to hospital engage-
ment, participant recruitment, questionnaire administra-
tion and providing feedback to hospitals that will inform
and enhance the feasibility of using this measure for the
national DUQuA study.
One key amendment to the PMOS, based on the
results of the ‘think aloud’, was the reduction of nega-
tively worded items from 56% to 28% (24–12 items) to
reduce the possibility of confusing, distressing or elicit-
ing unreliable answers from participants. The decision
Table 4 PMOS scores
Subscales (5-point Likert scale) Stroke M (SD) AMI M (SD) Hip M (SD) Total
Communication and team work 4.53 (0.61)* 4.50 (0.71) 4.13 (0.90) 4.40 (0.76)
Organisation and care planning 4.45 (0.65) 4.50 (0.94) 4.17 (0.86) 4.38 (0.81)
Access to resources 4.38 (0.80) 4.34 (0.87) 3.74 (1.23) 4.21 (0.97)
Ward type and layout 4.40 (0.83) 4.25 (0.88) 4.20 (1.12) 4.31 (0.93)
Information flow 4.50 (0.59) 4.38 (0.81) 4.29 (0.61)* 4.41 (0.66)
Roles and responsibilities 3.96 (1.13)† 4.13 (1.18)† 3.68 (1.36) 3.92 (1.22)
Staff training 4.46 (0.66) 4.69 (0.60)* 4.18 (0.53) 4.44 (0.63)*
Equipment (design and function) 4.43 (0.88) 4.47 (0.83) 4.00 (0.94) 4.31 (0.84)
Delays 4.30 (0.88) 4.20 (0.94) 3.11 (1.13)† 3.89 (1.11)†
PMOS negative index‡ 1.67 (1.56) 2.13 (2.23) 4.22 (3.70)† 2.59 (2.72)
*Ward-based subscale most favourable scores from patients.
†Ward-based subscale with least favourable scores from patients.
‡Represents the mean number of items that each patient scored negatively (ie, ≤2).6
AMI, acute myocardial infarction; M, median; PMOS, patient measure of safety.
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to make these changes is supported by previous research
with acutely ill hospitalised older adult patients, which
found that simpler questions are more effective.31 On
testing the revised version in phase 2, internal consist-
ency reliability was established for all but one subscale,
and differences were observed for the most and least
favourably rated areas of safety on the three wards.
However, the modest sample size within each ward did
not warrant statistical analysis of these differences. Item
analysis revealed three questions had been completed
with between 8 and 10 NA answers. It is understandable
that patients may not know the answers to these ques-
tions (eg, they may have had no way of knowing if their
test results had been delayed, or where the nurse’s
station is positioned to enable an opinion to be formed
about how this might have affected the difﬁculty of a
nurse’s job). In the deployment of the PMOS, partici-
pants should be encouraged to comment on why a par-
ticular question is not applicable to them in order to
support the explanation of results.
By piloting the PMOS, the research team have experi-
enced the process of administering the questionnaire
and have developed ideas for improving the feasibility of
using this measure with an older, vulnerable cohort of
patients (the mean age of patients in this study was
71.3 years, 17.3 years older than the sample used for the
original PMOS validation) for the DUQuA study.
Examples of some of the key feasibility ﬁndings include
Table 5 Key feasibility factors and implications for the DUQuA study
Key factors Findings from the pilot Implications for the DUQuA study
Ethics Identifying possible ethical issues for
working with vulnerable populations
Provide training in ethical research and clear
recruitment instructions to data collectors
coordinating PMOS
Liaising with wards Timing—understanding likely times for
discharge and working around this
Appreciating the nature of the individual
working wards and the best way to contact/
engage with the NUM
Design instructions for data collectors to ensure
they understand the need to find information about
discharge timing to make the process efficient.
Provide options in the instructions for data
collectors to present to wards to arrange data
collection
Questionnaire timing Identifying how long it takes to undertake the
questionnaire
Provide an experience-based estimate of the time
required in instructions for data collectors
Identifying patients Logistics for obtaining eligible patient names Emphasise importance of awareness of patient’s
name before approaching them, that is, train data
collectors to liaise with the NUMs to create a
system suited for the individual wards
Approaching patients Learning how to approach and talk to these
cohorts of patients
Provide scripts for data collectors detailing how to
approach the patients, and the order in which
information should be provided and requests for
participation made
Providing participant
with assistance
Assistance from family members or carers,
or the data collector
Provide scripts for data collectors to determine
whether a family member or carer may be willing to
assist the patient to complete the PMOS if the
patient is physically unable (eg, reading out the
questions, and/or circling the scales), interpret the
questionnaire (for non-English-speaking patients),
or if the patient would like assistance from the data
collector
Presentation of
information
Presentation of information sheets and
consent forms in an easy to use format
Provide data collectors with colour-coded paper to
simplify which documents belong to the patient or
data collector
Additional data Decisions about additional data that will be
important to factor into the analysis
Include item on questionnaire form to indicate
whether the patient completed the PMOS
independently, with assistance from the data
collector, or from a family member or carer
Specialised tools Tested the use of specialised tools
(eg, paper-based enlarged Likert scales)
Provide data collectors with laminated and enlarged
versions of the questionnaire and Likert scale
Providing hospitals with
recommendations
Identifying an appropriate level of practical
recommendations for the hospital and the
wards based on the findings
Consult with hospital leaders to ensure (1) the
hospital is provided with appropriate and feasible
recommendations and (2) the format of hospital
reports is pitched at an appropriate and valuable
level
DUQuA, Deepening our Understanding of Quality in Australia; NUM, nurse unit manager; PMOS, patient measure of safety.
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liaising with wards to understand operational procedures
and identify patterns of patient discharge. Making initial
contact with each of the NUMs to make a collaborative
decision about the days and times of day to call to learn
of new patient discharges and arrange subsequent visits
to the ward was crucial for the smooth recruitment of
patients. This was particularly important due to the
unpredictable nature of the discharge process, which
has been previously highlighted as a challenging point
at which to attempt to collect data from patients.32
While speciﬁc resources were developed for data collec-
tion based on recommendations from previous research
with acutely ill hospitalised older adult patients, this work
highlighted areas for improvement to the type and format
of resources that need to be provided. For example, in this
study, patients typically needed the research lead to read
aloud and ﬁll out the questionnaire based on their
answers, and were also provided with an enlarged (font
size 28) Likert scale to point to the rating of their choice.
However, ﬁndings indicated patients also preferred to see
the questionnaire while it was read aloud and often leaned
over from their bed towards the research lead’s version of
the PMOS, causing patients to move into a position that
was not ideal for their condition. As the research lead read
the questions aloud, it would have been useful to have
enlarged versions of the entire questionnaire and scale for
patients to view (eg, a minimum font size of 15 to ensure
letter height based on visual arc is sufﬁcient for viewing
capability)42 to ensure they were comfortable throughout
participation, a factor previously identiﬁed as important.34
Laminating these resources would enable the research
lead to easily identify them among the different sets of
documentation (eg, consent forms, information sheets,
revocation sheets, the questionnaire itself), and to reuse
them with all patients. Colour coding the documentation
would also have been beneﬁcial, to enable easy identiﬁca-
tion of the different paperwork.
Implications for health services research
The experiences in this PMOS pilot and feasibility study
have inﬂuenced key decisions for the use of this measure
in the national DUQuA study (table 5), and will inform
the design of future health services research studies meas-
uring patient perceptions. For example, detailed instruc-
tions and webinars have been developed for the DUQuA
data collectors to ensure they understand the need to
develop approaches for (1) engaging with the wards; (2)
ﬁnding information about timing of discharge; and (3)
determining when it is appropriate to visit the ward, to
minimise disruption for staff and to make the process efﬁ-
cient. These instructions include strategies that data col-
lectors can present to wards to arrange data collection.
Furthermore, the data collection resources (ie, laminated
versions of enlarged scales and complete questionnaires)
have been modiﬁed to maximise the ease for patients to
visualise and use the materials while maintaining a com-
fortable position, and to improve the logistics of the
process for the data collector.
This preliminary work also enabled the research team
to consider the format of feedback to provide to the par-
ticipating hospital and respective wards, an important
factor for bolstering senior healthcare management
decision-making for improvement based on research evi-
dence.43 Throughout the production and dissemination
of the hospital report based on this work, the research
team liaised and met with senior hospital leaders to
discuss the possible approaches in presenting feedback to
ensure that (1) the hospital and participating wards were
provided with appropriate and realistic recommendations
and (2) the reports for the cohort of DUQuA hospitals
will be pitched at an appropriate and valuable level.
Strengths and limitations
Factors including selection and investigator bias, random-
isation and the use of a control group could have been
improved within the study. For practical reasons, we had
to rely on the ward managers to identify the patients
based on their discharge lists for the day. While patients
were not randomly selected, the full list of patients due to
be discharged was used, and all patients on this list were
approached, removing an element of selection bias. The
investigator was chosen as an impartial, unbiased person
to administer the questionnaire, rather than members of
staff working on the ward, in order to reduce the risk of
patients providing responses that were more favourable
than their genuine perceptions (eg, for fear of offending
staff who may have directly cared for them). Limited
timeframes and the difﬁculty recruiting these types of
patients meant the decision to use a control group or
comparison questionnaire was not taken.
While only one hospital was used, it is typical of the
DUQuA hospital sample (ie, a tertiary metropolitan public
hospital that treats all three conditions, with ∼300 beds).
Furthermore, although this study used modest samples of
patients in each phase, the sample was representative
of the forthcoming DUQuA study population (ie, in terms
of the inclusion criteria, including the primary diagnosis
for admission—fully speciﬁed in the DUQuA study proto-
col9), which bolsters the ecological validity of this feasibility
test. The sample size across individual wards did not allow
for statistical analysis of ward differences that were
observed. Nonetheless, internal consistency reliability was
established for all but one subscale, and the DUQuA study
aims to test the PMOS with 1800 patients from each condi-
tion (5400 total) across 60 hospitals. Therefore, sample
sizes to detect differences between wards for patient
ratings of these areas of safety will be adequately powered.
Despite the small sample size, feedback to the research
team from the hospital has indicated value in the results
for generating ideas for targeted improvement.
CONCLUSION
For the ﬁrst time internationally, a cohort of vulnerable
patients provided their perceptions of the care they
received on the respective wards using the PMOS, a tool
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that highlights evidence-based contributory factors to
the delivery of safe patient care, and signals areas for
hospitals to target for improvement. Ensuring that the
questionnaire is appropriate for use with these patient
groups is highly signiﬁcant for the DUQuA study, and
will inform the deployment of this questionnaire nation-
ally, and of future health services research projects. With
a larger, more representative sample, DUQuA will
further strengthen the validity and reliability of the
PMOS for the beneﬁt of Australian and international
hospitals and institutions. The DUQuA study will also
assess the strength of relationships between the PMOS
and the way hospitals are set up for quality and safety,
the way care is delivered, and patient outcomes.
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